Document Detail


Prior statin use may be associated with improved stroke outcome after tissue plasminogen activator.
MedLine Citation:
PMID:  17272777     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND AND PURPOSE: Statins may exert some neuroprotection, because use before stroke onset has been related to better outcome and reduced mortality. The purpose of this study was to evaluate whether patients who receive tissue plasminogen activator have better outcome when statins were taken before stroke. METHODS: We evaluated 145 patients with a stroke involving the middle cerebral artery (who received tissue plasminogen activator treatment (<3 hours). RESULTS: Fifty-eight patients (40%) became functionally independent at 3 months. Factors associated with good outcome were age (68 versus 74.4 years, P<0.001), baseline National Institutes of Health Stroke Scale score (13 versus 18, P<0.001), and proximal middle cerebral artery occlusion (56.1% versus 84.3%, P<0.001). Statins were the only drug taken before stroke that conditioned neurologic outcome. In fact, among patients who were functionally independent, 27.3% were under statins at the time of the index stroke as compared with 13.6% among the group of patients who were dependent or dead by the end of the study period (P=0.046). A logistic regression model identified baseline National Institutes of Health Stroke Scale score <15 (OR: 5.8, 95% CI: 2.05 to 16.36, P=0.001), age <70 years (OR: 2.93, 95% CI: 1.13 to 7.59, P=0.027), and previous treatment with statins (OR: 5.26, 95% CI: 1.48 to 18.72, P=0.027) as independent predictors of good functional outcome. CONCLUSIONS: Patients under statins at the moment of stroke who received thrombolytics had an improved neurologic outcome.
Authors:
José Alvarez-Sabín; Rafael Huertas; Manolo Quintana; Marta Rubiera; Pilar Delgado; Marc Ribó; Carlos A Molina; Joan Montaner
Related Documents :
9617597 - Triflusal.
19373427 - Long-term mortality and risk of stroke after transient ischemic attack: a hospital-base...
20801767 - Bringing forward reperfusion with oxygenated blood perfusion beyond arterial occlusion ...
10204657 - Carotid duplex ultrasonography: importance of standardisation. asymptomatic carotid sur...
12521827 - Grandmultiparity--trends and complications: a study in two hospital settings.
24952857 - Rationale and design of prima ii: a multicenter, randomized clinical trial to study the...
Publication Detail:
Type:  Comparative Study; Journal Article     Date:  2007-02-01
Journal Detail:
Title:  Stroke; a journal of cerebral circulation     Volume:  38     ISSN:  1524-4628     ISO Abbreviation:  Stroke     Publication Date:  2007 Mar 
Date Detail:
Created Date:  2007-02-27     Completed Date:  2007-03-19     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  0235266     Medline TA:  Stroke     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1076-8     Citation Subset:  IM    
Affiliation:
Neurovascular Research Laboratory, Neurovascular Unit, Neurology Department, Hospital Universitario Vall d'Hebron, Barcelona, Spain.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Aged, 80 and over
Female
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors / administration & dosage*,  therapeutic use
Male
Retrospective Studies
Stroke / drug therapy*,  epidemiology,  physiopathology
Time Factors
Tissue Plasminogen Activator / administration & dosage*
Treatment Outcome
Chemical
Reg. No./Substance:
0/Hydroxymethylglutaryl-CoA Reductase Inhibitors; EC 3.4.21.68/Tissue Plasminogen Activator

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Differential prognosis of isolated cortical swelling and hypoattenuation on CT in acute stroke.
Next Document:  Influence of hyperglycemia on oxidative stress and matrix metalloproteinase-9 activation after focal...